{"slideshow_credits": null, "snippet": "Endo\u2019s deal for Paladin Labs of Canada will involve creating a new holding company based in Ireland to house both firms. The move should significantly reduce Endo\u2019s tax rate.", "abstract": "Endo\u2019s deal for Paladin Labs of Canada will involve creating a new holding company based in Ireland to house both firms. The move should significantly reduce Endo\u2019s tax rate.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://dealbook.nytimes.com/2013/11/05/the-tax-motive-in-endo-healths-deal/", "lead_paragraph": null, "headline": {"main": "The Tax Motive in Endo Health's Deal ", "kicker": "DealBook"}, "_id": "527957b438f0d82673908746", "word_count": "382", "multimedia": [], "pub_date": "2013-11-05T15:38:07Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "glocations", "value": "Ireland", "rank": "1"}, {"name": "glocations", "value": "Montreal (Quebec)", "rank": "2"}, {"name": "glocations", "value": "Pennsylvania", "rank": "3"}, {"name": "organizations", "value": "Elan Corporation PLC", "rank": "1"}, {"name": "organizations", "value": "Endo Pharmaceuticals Holdings Inc", "rank": "2"}, {"name": "organizations", "value": "Paladin Laboratories Incorporated", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}